Non‐Michaelis–Menten Type Hepatic Uptake of Liposomes in the Rat

Abstract— The objective of this study was to verify the methodology for measuring uptake clearance of liposomes and to characterize kinetically the saturable hepatic uptake of liposomes through phagocytosis. The correction of vascular space was important in the evaluationof hepatic uptake. The efflux of liposomes from liver was shown to be negligible, by a repeated dose study, and thus, hepatic clearance can be obtained by the hepatic uptake divided by the area under the blood concentration‐time curve (AUC). The determinant parameter which describes the saturability of uptake clearance of liposomes, independent of infusion rate, was investigated, using the data of an in‐vivo constant infusion study, where infusion rate‐dependent saturable hepatic clearance was observed. The mean blood concentration failed to obtain an infusion rate‐independent function. On the other hand, the AUC could explain the saturability of hepatic clearance for every infusion rate by a unique relationship. The hepatic uptake amount could also explain this saturability, independent of infusion rate. These kinetic characteristics are inconsistent with Michaelis–Menten type kinetics, therefore a new model is required to describe the saturable hepatic clearance in the disposition of liposomes.

[1]  H. Harashima,et al.  Saturable, Non‐Michaelis‐Menten Uptake of Liposomes by the Reticuloendothelial System , 1991, The Journal of pharmacy and pharmacology.

[2]  D. Papahadjopoulos,et al.  Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay. , 1990, Biochimica et biophysica acta.

[3]  G. Gregoriadis The Physiology of the Liposome , 1989 .

[4]  M. Padki,et al.  Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect. , 1989, The Journal of pharmacology and experimental therapeutics.

[5]  J. Sculier,et al.  Pharmacokinetics of Amphotericin B in Patients Receiving Repeated Intravenous High Doses of Amphotericin B Entrapped into Sonicated Liposomes , 1989 .

[6]  F. Roerdink,et al.  Drug Carrier Systems , 1989 .

[7]  G. Lázár,et al.  Targeting of liposomes to liver cells. , 1989, Horizons in biochemistry and biophysics.

[8]  R. Juliano Liposomes as drug carriers in the therapy of infectious diseases. , 1989, Horizons in biochemistry and biophysics.

[9]  R. Juliano Factors affecting the clearance kinetics and tissue distribution of liposomes, microspheres and emulsions , 1988 .

[10]  S. Becker Functions of the human mononuclear phagocyte system (a condensed review) , 1988 .

[11]  H. Kiwada,et al.  Effects of dose and vesicle size on the pharmacokinetics of liposomes. , 1986, Chemical & pharmaceutical bulletin.

[12]  K Yamaoka,et al.  A nonlinear least squares program based on differential equations, MULTI (RUNGE), for microcomputers. , 1983, Journal of pharmacobio-dynamics.

[13]  P. Beaumier,et al.  Effects of liposome size on the degradation of bovine brain sphingomyelin/cholesterol liposomes in the mouse liver. , 1983, Biochimica et biophysica acta.

[14]  D. Friend,et al.  Endocytosis of liposomes and intracellular fate of encapsulated molecules: Encounter with a low pH compartment after internalization in coated vesicles , 1983, Cell.

[15]  P. Beaumier,et al.  Effect of liposome dose on the elimination of small unilamellar sphingomyelin/cholesterol vesicles from the circulation. , 1983, Research communications in chemical pathology and pharmacology.

[16]  R. Steinman,et al.  Endocytosis and the recycling of plasma membrane , 1983, The Journal of cell biology.

[17]  C. Bucana,et al.  Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. , 1982, Cancer research.

[18]  C. Hunt,et al.  Liposome disposition in vivo II: Dose dependency. , 1982, Journal of pharmaceutical sciences.

[19]  C. Hunt,et al.  Liposome disposition in vivo. III. Dose and vesicle-size effects. , 1981, Biochimica et biophysica acta.

[20]  R. Juliano,et al.  Interactions of liposomes with the reticuloendothelial system. Effects of reticuloendothelial blockade on the clearance of large unilamellar vesicles. , 1981, Biochimica et biophysica acta.

[21]  J. Dijkstra,et al.  The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes. Effects of lanthanum and gadolinium salts. , 1981, Biochimica et biophysica acta.

[22]  T Nakagawa,et al.  A pharmacokinetic analysis program (multi) for microcomputer. , 1981, Journal of pharmacobio-dynamics.

[23]  G. Weissmann,et al.  The introduction of enzymes into cells by means of liposomes. , 1978, Journal of lipid research.

[24]  C V Greenway,et al.  Hepatic vascular bed. , 1971, Physiological reviews.

[25]  T. Saba Physiology and physiopathology of the reticuloendothelial system. , 1970, Archives of internal medicine.

[26]  E. Wisse,et al.  An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. , 1970, Journal of ultrastructure research.